Pallas Capital Advisors »

Heron Therapeutics shares owned by Pallas Capital Advisors

Quarter-by-quarter ownership of Heron Therapeutics (HRTX) shares owned by Pallas Capital Advisors from 13F filings

Historical chart of Pallas Capital Advisors investment in Heron Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Heron Therapeutics held by Pallas Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Heron Therapeutics by Pallas Capital Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $11k 26k 0.43

More positions owned by Pallas Capital Advisors

Bruker Corporation (BRKR)
Global Partners Com Units (GLP)
Janus Detroit Str Tr Henderson Mtg (JMBS)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Schwab Strategic Tr Fundamental Intl (FNDF)
Dimensional Etf Trust Internatnal Val (DFIV)
Fidelity Covington Trust Enhanced Intl (FENI)
Fidelity Merrimack Str Tr Total Bd Etf (FBND)
Broadcom (AVGO)
Dimensional Etf Trust Intl Core Eqt Mk (DFAI)
J P Morgan Exchange Traded F Active Bond Etf (JBND)

View all positions for Pallas Capital Advisors

Top funds holding Heron Therapeutics

Rubric Capital Management
Clearline Capital
BlackRock
Velan Capital Investment Management
Vanguard Capital Management
Tejara Capital
Tang Capital Management
Geode Capital Management
Millennium Management
State Street Corporation
JW Asset Management
Caption Management
UBS Group
Pale Fire Capital SE
Marshall Wace

View all funds holding Heron Therapeutics